1. Home
  2. ZYME vs ARLO Comparison

ZYME vs ARLO Comparison

Compare ZYME & ARLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$26.43

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Arlo Technologies Inc.

ARLO

Arlo Technologies Inc.

HOLD

Current Price

$13.21

Market Cap

2.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
ARLO
Founded
2003
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
ZYME
ARLO
Price
$26.43
$13.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
2
Target Price
$32.75
$24.00
AVG Volume (30 Days)
589.6K
1.1M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$134,481,000.00
$509,572,000.00
Revenue This Year
$63.57
$4.76
Revenue Next Year
$89.45
$7.31
P/E Ratio
N/A
$344.76
Revenue Growth
116.21
N/A
52 Week Low
$9.03
$7.84
52 Week High
$28.49
$19.94

Technical Indicators

Market Signals
Indicator
ZYME
ARLO
Relative Strength Index (RSI) 57.49 37.66
Support Level $26.10 $13.54
Resistance Level $26.91 $14.14
Average True Range (ATR) 0.95 0.50
MACD -0.25 0.05
Stochastic Oscillator 49.84 3.78

Price Performance

Historical Comparison
ZYME
ARLO

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About ARLO Arlo Technologies Inc.

Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It combines a cloud infrastructure and mobile app with various smart connected devices to provide users with visibility, insight, and a means to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.

Share on Social Networks: